Di Zenzo G - Search Results

1

Bullous Pemphigoid: Trigger and Predisposing Factors.

Moro F, Fania L, Sinagra JLM, Salemme A, Di Zenzo G. Moro F, et al. Among authors: di zenzo g. Biomolecules. 2020 Oct 10;10(10):1432. doi: 10.3390/biom10101432. Biomolecules. 2020. PMID: 33050407 Free PMC article. Review.

2

Development of a novel ELISA system for detection of anti-BP180 IgG and characterization of autoantibody profile in bullous pemphigoid patients.

Mariotti F, Grosso F, Terracina M, Ruffelli M, Cordiali-Fei P, Sera F, Zambruno G, Mastrogiacomo A, Di Zenzo G. Mariotti F, et al. Among authors: di zenzo g. Br J Dermatol. 2004 Nov;151(5):1004-10. doi: 10.1111/j.1365-2133.2004.06245.x. Br J Dermatol. 2004. PMID: 15541078

3

Bullous pemphigoid: physiopathology, clinical features and management.

Di Zenzo G, Marazza G, Borradori L. Di Zenzo G, et al. Adv Dermatol. 2007;23:257-88. doi: 10.1016/j.yadr.2007.07.013. Adv Dermatol. 2007. PMID: 18159905 Review.

4

Multicenter prospective study of the humoral autoimmune response in bullous pemphigoid.

Di Zenzo G, Thoma-Uszynski S, Fontao L, Calabresi V, Hofmann SC, Hellmark T, Sebbag N, Pedicelli C, Sera F, Lacour JP, Wieslander J, Bruckner-Tuderman L, Borradori L, Zambruno G, Hertl M. Di Zenzo G, et al. Clin Immunol. 2008 Sep;128(3):415-26. doi: 10.1016/j.clim.2008.04.012. Epub 2008 Jun 20. Clin Immunol. 2008. PMID: 18571472

5

Demonstration of epitope-spreading phenomena in bullous pemphigoid: results of a prospective multicenter study.

Di Zenzo G, Thoma-Uszynski S, Calabresi V, Fontao L, Hofmann SC, Lacour JP, Sera F, Bruckner-Tuderman L, Zambruno G, Borradori L, Hertl M. Di Zenzo G, et al. J Invest Dermatol. 2011 Nov;131(11):2271-80. doi: 10.1038/jid.2011.180. Epub 2011 Jun 23. J Invest Dermatol. 2011. PMID: 21697892 Free article.

6

Bullous pemphigoid: from the clinic to the bench.

Di Zenzo G, Della Torre R, Zambruno G, Borradori L. Di Zenzo G, et al. Clin Dermatol. 2012 Jan-Feb;30(1):3-16. doi: 10.1016/j.clindermatol.2011.03.005. Clin Dermatol. 2012. PMID: 22137222 Review.

7

Detection and characterization of IgG, IgE, and IgA autoantibodies in patients with bullous pemphigoid associated with dipeptidyl peptidase-4 inhibitors.

Fania L, Salemme A, Provini A, Pagnanelli G, Collina MC, Abeni D, Didona B, Di Zenzo G, Mazzanti C. Fania L, et al. Among authors: di zenzo g. J Am Acad Dermatol. 2018 Mar;78(3):592-595. doi: 10.1016/j.jaad.2017.09.051. Epub 2017 Oct 4. J Am Acad Dermatol. 2018. PMID: 28987492 No abstract available.

8

Increased prevalence of diabetes mellitus in bullous pemphigoid patients during the last decade.

Fania L, Di Zenzo G, Didona B, Pilla MA, Sobrino L, Panebianco A, Mazzanti C, Abeni D. Fania L, et al. Among authors: di zenzo g. J Eur Acad Dermatol Venereol. 2018 Apr;32(4):e153-e154. doi: 10.1111/jdv.14649. Epub 2017 Nov 7. J Eur Acad Dermatol Venereol. 2018. PMID: 29055144 No abstract available.

9

Commentary on 'Changing prevalence of diabetes mellitus in bullous pemphigoid: it is the dipeptidyl peptidase-4 inhibitors'.

Fania L, Di Zenzo G, Mazzanti C, Abeni D. Fania L, et al. Among authors: di zenzo g. J Eur Acad Dermatol Venereol. 2018 Dec;32(12):e439-e440. doi: 10.1111/jdv.14965. Epub 2018 May 3. J Eur Acad Dermatol Venereol. 2018. PMID: 29569809 No abstract available.

10

Bullous pemphigoid: Italian guidelines adapted from the EDF/EADV guidelines.

Cozzani E, Marzano AV, Caproni M, Feliciani C, Calzavara-Pinton P; Cutaneous Immunology group of SIDeMaST. Cozzani E, et al. G Ital Dermatol Venereol. 2018 Jun;153(3):305-315. doi: 10.23736/S0392-0488.18.06006-6. Epub 2018 Mar 30. G Ital Dermatol Venereol. 2018. PMID: 29600832 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

113 results

Search Page